The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter

被引:73
作者
El Mai, Mounir [1 ]
Wagner, Kay-Dietrich [1 ]
Michiels, Jean-Francois [1 ,2 ]
Ambrosetti, Damien [1 ,2 ]
Borderie, Arnaud [2 ]
Destree, Sandrine [2 ]
Renault, Valerie [1 ]
Djerbi, Nadir [1 ]
Giraud-Panis, Marie-Josephe [1 ]
Gilson, Eric [1 ,3 ]
Wagner, Nicole [1 ]
机构
[1] Univ Nice Sophia Antipolis, Inst Res Canc & Aging Nice, Nice IRCAN, CNRS,UMR7284,INSERM,U1081,Fac Med, F-06107 Nice, France
[2] Ctr Hosp Univ Nice, Dept Pathol, F-06107 Nice, France
[3] Ctr Hosp Univ Nice, Dept Med Genet, F-06107 Nice, France
关键词
GROWTH-FACTOR RECEPTOR; TUMOR SUPPRESSOR WT1; CELL-PROLIFERATION; GENE-EXPRESSION; DNA-DAMAGE; CANCER; RAP1; CARCINOMA; APOPTOSIS;
D O I
10.1016/j.celrep.2014.09.038
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomeric repeat binding factor 2 (TRF2), which plays a central role in telomere capping, is frequently increased in human tumors. We reveal here that TRF2 is expressed in the vasculature of most human cancer types, where it colocalizes with the Wilms' tumor suppressor WT1. We further show that TRF2 is a transcriptional target of WT1 and is required for proliferation, migration, and tube formation of endothelial cells. These angiogenic effects of TRF2 are uncoupled from its function in telomere capping. Instead, TRF2 binds and transactivates the promoter of the angiogenic tyrosine kinase platelet-derived growth factor receptor beta (PDGFR beta). These findings reveal an unexpected role of TRF2 in neoangiogenesis and delineate a distinct function of TRF2 as a transcriptional regulator.
引用
收藏
页码:1047 / 1060
页数:14
相关论文
共 48 条
[1]   PDGF-BB MODULATES ENDOTHELIAL PROLIFERATION AND ANGIOGENESIS IN-VITRO VIA PDGF BETA-RECEPTORS [J].
BATTEGAY, EJ ;
RUPP, J ;
IRUELAARISPE, L ;
SAGE, EH ;
PECH, M .
JOURNAL OF CELL BIOLOGY, 1994, 125 (04) :917-928
[2]   Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas [J].
Begemann, Sebastian ;
Galimi, Francesco ;
Karlseder, Jan .
AGING-US, 2009, 1 (01) :122-130
[3]  
Bhardwaj B, 1996, CLIN CANCER RES, V2, P773
[4]   TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells [J].
Biroccio, Annamaria ;
Rizzo, Angela ;
Elli, Raffaella ;
Koering, Catherine-Elaine ;
Belleville, Aurelie ;
Benassi, Barbara ;
Leonetti, Carlo ;
Stevens, Malcolm F. G. ;
D'Incalci, Maurizio ;
Zupi, Gabriella ;
Gilson, Eric .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) :1881-1888
[5]   TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells [J].
Biroccio, Annamaria ;
Cherfils-Vicini, Julien ;
Augereau, Adeline ;
Pinte, Sebastien ;
Bauwens, Serge ;
Ye, Jing ;
Simonet, Thomas ;
Horard, Beatrice ;
Jamet, Karine ;
Cervera, Ludovic ;
Mendez-Bermudez, Aaron ;
Poncet, Delphine ;
Grataroli, Renee ;
de Rodenbeeke, Claire T'kint ;
Salvati, Erica ;
Rizzo, Angela ;
Zizza, Pasquale ;
Ricoul, Michelle ;
Cognet, Celine ;
Kuilman, Thomas ;
Duret, Helene ;
Lepinasse, Florian ;
Marvel, Jacqueline ;
Verhoeyen, Els ;
Cosset, Francois-Loic ;
Peeper, Daniel ;
Smyth, Mark J. ;
Londono-Vallejo, Arturo ;
Sabatier, Laure ;
Picco, Vincent ;
Pages, Gilles ;
Scoazec, Jean-Yves ;
Stoppacciaro, Antonella ;
Leonetti, Carlo ;
Vivier, Eric ;
Gilson, Eric .
NATURE CELL BIOLOGY, 2013, 15 (07) :818-+
[6]   Telomeres and telomerase:: the path from maize, Tetrahymena and yeast to human cancer and aging [J].
Blackburn, Elizabeth H. ;
Greider, Carol W. ;
Szostak, Jack W. .
NATURE MEDICINE, 2006, 12 (10) :1133-1138
[7]   Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis [J].
Blanco, Raquel ;
Munoz, Purificacion ;
Flores, Juana M. ;
Klatt, Peter ;
Blasco, Maria A. .
GENES & DEVELOPMENT, 2007, 21 (02) :206-220
[8]   The Telomere Deprotection Response Is Functionally Distinct from the Genomic DNA Damage Response [J].
Cesare, Anthony J. ;
Hayashi, Makoto T. ;
Crabbe, Laure ;
Karlseder, Jan .
MOLECULAR CELL, 2013, 51 (02) :141-155
[9]   The levels of telomere-binding proteins in human tumours and therapeutic implications [J].
Cookson, J. C. ;
Laughton, C. A. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (04) :536-550
[10]   WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes [J].
Davies, RC ;
Calvio, C ;
Bratt, E ;
Larsson, SH ;
Lamond, AI ;
Hastie, ND .
GENES & DEVELOPMENT, 1998, 12 (20) :3217-3225